US EditionPandemic disruptions to health care worsened cancer survival, study suggests
More than 1 million U.S. cancer patients diagnosed in 2020-21 had lower one-year survival, possibly due to pandemic-related care disruptions, researchers said.
- Thursday's JAMA Oncology report, funded by federal grants, found worse one-year survival for cancer patients diagnosed in 2020 and 2021 based on U.S. national cancer-registry data.
- Due to postponed screenings and strained hospitals, investigators found COVID-19 disruptions to colonoscopies, mammograms, and lung scans likely reduced access and timeliness of treatment.
- More than 1 million people were diagnosed in 2020 and 2021, about 144,000 died within one year, and researchers estimated about 17,400 excess deaths relative to 2015–2019 expectations.
- The study's authors cautioned they could not definitively identify causal drivers, noting further research will be needed to see if impacts are lasting, as researchers filtered out COVID-19 deaths to isolate other contributors.
- Earlier research found overall U.S. cancer death rates continued to decline during the pandemic, while the federally funded study is important for ongoing evaluation of pandemic effects, Recinda Sherman said.
71 Articles
71 Articles
Pandemic disruptions to health care worsened cancer survival, study suggests - The Boston Globe
Researchers found that people diagnosed with cancer in 2020 and 2021 had worse short-term survival than those diagnosed between 2015 and 2019. That was true across a range of cancers, and whether they were diagnosed at a late or early stage.
MedPage Today
Anti-Aging, Acupuncture and Health NewsPandemic Disruptions Worsened Cancer Survival, Study Finds
(MedPage Today) -- People diagnosed with cancer during the first 2 years of the COVID-19 pandemic had worse short-term survival compared with cases in the years leading up to the pandemic, including for breast, prostate, colorectal, and other cancers...
During the early years of the COVID-19 pandemic, experts feared that interruptions in the diagnosis and treatment of cancer would cost lives.A new study suggests they were right.The study funded by the U.S. government and published by the medical journal JAMA Oncology would so far be the first to assess the effects of pandemic-related interruptions on short-term survival of cancer patients. Researchers found that people diagnosed with cancer in …
During the early years of the COVID-19 pandemic, experts feared that disruptions to cancer diagnosis and treatment would cost lives. A new study suggests they were right.
Coverage Details
Bias Distribution
- 64% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
